Response to Relapse in Office-Based Opioid Treatment Trial

NATerminatedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

March 12, 2020

Study Completion Date

March 12, 2020

Conditions
Opioid-use Disorder
Interventions
OTHER

Moderate Treatment Approach

The frequency of visits will be organized similarly as the intensive treatment arm (weekly, every 2 weeks, and every 4 weeks) but participants in this arm will be able to move more freely between these steps and are hypothesized to require fewer provider visits than the intensive treatment arm.

OTHER

Intensive Treatment Approach

After stabilization on a MOUD, participants who relapse will be asked to return weekly until 2 consecutive urine drug tests are negative for opioids or other illicit drugs. Participants will then be asked to return every other week until 2 consecutive urine drug tests are negative for opioids or other illicit drugs, before being asked to return every 4 weeks. If the participant tests positive for illicit drugs while returning every other week, they will return to the beginning of the treatment plan (2 consecutive negative tests before going to every other week).

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Substance Abuse and Mental Health Services Administration (SAMHSA)

FED

lead

Boston Medical Center

OTHER

NCT03812107 - Response to Relapse in Office-Based Opioid Treatment Trial | Biotech Hunter | Biotech Hunter